ERBB2 and neoplasm: The anti-HER2×PD1 not only activated T cells and induced ADCC to eliminate HER2-expressing tumor cells but also linked tumor cells and T cells, forming an immunological synapse that achieved tumor killing that did not require antigen presentation [217].